ICSMA-16-306-01

icsaUScisa_csaf_ot

Smiths Medical CADD-Solis Medication Safety Software Vulnerabilities

Advisory ansehen veröffentlicht 2016-08-05

This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

01

beschreibt (2)

Zugehörige CVEs.

IDSchweregrad ausnutzbar
CVE-2016-8358UShigh8.5—
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communicati…
CVE-2016-8355UScritical9.9OT erhöht—
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user…
02

Referenzen

Externe Belege — Patches, Meldungen, Analysen.

03

Behebungen (2)

  • MitigationCADD-Solis Medication Safety Software

    Smiths Medical has released new versions of the CADD-Solis Medication Safety Software, which mitigates the identified vulnerabilities. The new versions of Smiths Medical’s CADD-Solis Medication Safety Software are Version 3.2, which is distributed within the continental US, and Version 4.1, which is released outside the continental US.

  • MitigationCADD-Solis Medication Safety Software

    Smiths Medical has released new versions of the CADD-Solis Medication Safety Software, which mitigates the identified vulnerabilities. The new versions of Smiths Medical’s CADD-Solis Medication Safety Software are Version 3.2, which is distributed within the continental US, and Version 4.1, which is released outside the continental US.

scry

Advisories wie diese benennen die exponierten Produkte, die Angreifer auf Ihrer Angriffsfläche ins Visier nehmen. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.

Kostenloser Scan